Spatial Tracking of Targeted Prostate Biopsy Locations: Moving Towards Effective Focal Partial Prostate Gland

Steven Sidelsky1, Shaan Setia1, Srinivas Vourganti2

  • 1Division of Urology, Rush University Medical Center, 1725 W. Harrison Street, POB III Suite 970, Chicago, IL, 60612, USA.

Current Urology Reports
|October 20, 2017
PubMed

Insights

Accurately identifying aggressive prostate cancer areas is key for focal therapy. Advanced imaging and biopsy techniques like MRI and MR/US fusion improve precision in locating high-grade lesions for targeted treatment.

Area of Science:

  • Urology
  • Oncology
  • Medical Imaging

Background:

  • Optimal prostate cancer therapy requires precise identification of aggressive areas.
  • Focal therapy offers a targeted approach, necessitating accurate localization of high-grade lesions.

Purpose of the Study:

  • To highlight contemporary target tracking techniques for focal therapy planning in prostate cancer.
  • To discuss the role of advanced imaging in localizing potentially aggressive prostate cancer sites.

Main Methods:

  • Review of contemporary techniques in target tracking for focal therapy.
  • Emphasis on multiparametric magnetic resonance imaging (mpMRI) for lesion localization.
  • Discussion of in-bore MRI biopsy and MR/US fusion biopsy (cognitive and software-enhanced co-registration).

Main Results:

  • Multiparametric MRI is a dominant strategy for localizing biopsy sites with high-grade lesions.
  • In-bore MRI biopsy and MR/US fusion biopsy are common strategies for precise localization.
  • These advances contribute to optimism in focal therapy for prostate cancer.

Conclusions:

  • Accurate characterization and localization of aggressive prostate cancer are crucial for focal therapy.
  • Advanced MRI and biopsy techniques enhance the precision of focal therapy planning.
  • Progress in these areas fuels optimism for the future of prostate cancer focal therapy.

Related Concept Videos